5243422026-01-012026-03-315243422026-03-315243422025-03-315243422025-04-012026-03-315243422026-01-012026-03-31in-capmkt:OtherExpenses1Member5243422025-04-012026-03-31in-capmkt:OtherExpenses1Member5243422026-03-31OtherNoncurrentFinancialAssetsDomain15243422026-03-31OtherCurrentFinancialAssetsDomain15243422026-03-31OtherCurrentAssetsDomain15243422026-03-31OtherNoncurrentFinancialLiabilitiesDomain15243422026-03-31OtherNoncurrentLiabilitiesDomain15243422026-03-31OtherCurrentFinancialLiabilitiesDomain15243422026-03-31OtherCurrentFinancialLiabilitiesDomain25243422026-03-31OtherCurrentFinancialLiabilitiesDomain35243422026-03-31OtherCurrentFinancialLiabilitiesDomain45243422026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15243422026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25243422025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15243422025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25243422026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares524342INDOBORAXNOTLISTEDINE803D01021INDO BORAX & CHEMICALS LIMITEDMain BoardEquity2025-04-012026-03-312026-05-212026-05-18INRLakhsQuarterlyFourth quarterSingle segmentManufacturer of Chemicals2026-05-2111:30:002026-05-2114:10:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated630107000451930006753000003617040000-34101000730950006470006341000101175000508861000166439000800300017444200039484000-103650002911900001453230000000145323000128480001581710001581710000003209000014.534.53004.534.531. The above results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at its meeting held on 21st May, 2026.There are no qualifications in the audit report for the year ended 31st March, 2026 <BR> 2.The Board of Directors on 21st May, 2026 have recommended the payment of Final dividend of Rs. 10 /- (Rupees Ten only, @ 1000 %) per equity shares of the face value of Rs. 1/- each and Special dividend of Rs 30/- ( Rupees Thirty only , @ 3000 %) per Equity shares of the Face Value of Rs. 1/- each . The recommended dividend ( Final and Special ) is subject to the approval of the shareholders at the ensuing Annual General Meeting <BR> 3.The Company, on standalone basis, has only one segment of activity namely "Manufacturing and selling of Chemicals", the disclosure requirement of the Indian Accounting Standard (AS) 108 "Operating Segment" notified under Section 133 of the Companies Act, 2013 read with Rule 7 of the Companies (Accounts) Rule, 2014 are not applicable. <BR> 4.Effective 21 Novemeber 2025 , the Govt of India has consolidated multiple existing labour legislations into a United Framework comprising four Labour Code Collectively referred to as the ' The New Labour Codes' . Under IND AS 19 changes to Employees Benefit plan arising from legislative amendements . The company has accounted the same in Profit & Loss account and there in no material impact on Financial Statements. <BR> 5.The figures of last quarter ended March 31,2026 and March 31, 2025 are the balancing figures between audited figures in respect of the full financial year and the Unaudited published year-to-date figures upto the third quarter ended December 31, 2025 and December 31,2024 respectively the respective financial year. <BR> 6.The statutory Auditor have expressed an unmodified audit opinion. <BR> 7.The figures of the previous year have been regrouped /rearranged, wherever considered necessary, to make them comparable with the figures for the current year. <BR> 8.The Standalone and Consolidated results of the Company are available on the Company's website www.indoborax.com and also available on the websites of the BSE Ltd and National Stock Exchanage of India Ltd <BR> <BR> 2025-04-012026-03-31AuditedConsolidated21545110001543550002308866000114330300027686000-35558000178021000661000315690003994720001745154000563712000101475000665187000180988000-184990001624890000502698000000050269800040891000543589000543589000000320900001383374000015.6715.670015.6715.67Other Expenses101175000Other Expenses399472000770780001125200038514800001384300000011719100006305500013652400031677000008040910003182750001977045000103792000136092000290800011040005907470002811688000114668000324463100040487220003209000038337400003865830000386583000000001727400017274000039000095960002726000000309850003098500012464700015563200001556320001828920004048722000Other Financial Asset136524000Other current financial assets590747000Other current assets114668000Other Financial Liabilities17274000Lease Liabilities9596000Other current financial liabilities99002000lease liabilities4704000Employee Benefit Obligation20516000Income tax liabilities (Net)425000661000152400000413970000-366240000697076000-2767100000-233330000110290000315690000-423500000-11300000964500079463000000-1095410001373900000407190000107237700000020087100008715060000017548070003228300000000019545400029110000-42500000000000000000000096450007943300000-7668720000000000000032090000280200000-348920006974200006974200066350000136092000Valuation effect of Investment at Market value9327000Effect of Acturial valuation of Employee benfits200600011333000Valuation effect of Investment at Market value42402000Effect of Acturial valuation of Employee benfits130900043711000-15150002820000001284800040891000AuditedtrueBohra & Cotrue2027-03-31